CereVasc
PrivateLast Round
Series C
Jun 4, 2026
Total Funding Raised
$198.9M
Momentum Score
50 /100
Company Overview
CereVasc is a medical device company that develops innovative endovascularly implantable CSF shunts and delivery systems to treat neurological diseases with minimally invasive procedures, reducing the need for invasive surgery and associated complications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CereVasc Comps
Public and private peers based on sector, stage, and business model.
CereVasc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 4, 2026 | ||||
| Series B | May 13, 2024 | ||||
| Series A | Jun 9, 2020 |
Key People
Founding team and executive leadership
CereVasc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series C, Series B |
| Xontogeny | Series B, Series A |
| Perceptive Xontogeny Ventures | Series C |
| Perceptive Xontogeny Venture Fund | Series A, Series B |
| Bain Capital, LP | Series B |
| Johnson & Johnson Innovation - JJDC, Inc. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$85M round led by Piper Sandler & Co.
CereVasc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CereVasc's valuation, stock price, and market status.
